Refresh

Natco Pharma Ltd. - Research Center

524816 NATCOPHARM Group (A) BSE data
Back to Company

Results

Statement

More

Annual results in brief
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20

Sales

3,568.90 2,351.00 1,767.80 1,653.50 1,790.20

Operating profit

1,637.00 844.70 213.00 417.60 578.00

Interest

14.50 8.60 13.30 11.30 20.60

Gross profit

1,727.20 921.60 294.30 507.40 681.20

EPS (Rs)

72.99 34.91 7.62 16.96 26.07
Annual  results in details
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20

Other income

104.70 85.50 94.60 101.10 123.80

Stock adjustment

17.20 34.60 -5.50 -46.90 -55.90

Raw material

522.50 475.30 519.20 372.90 329.00

Power and fuel

- - - - -

Employee expenses

454.90 425.70 410.10 380.00 356.10

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

937.30 570.70 631.00 529.90 583.00

Provisions made

- - - - -

Depreciation

171.90 150.90 138.40 115.20 98.10

Taxation

248.70 133.60 16.80 82.70 108.60

Net profit / loss

1,306.60 637.10 139.10 309.50 474.50

Extra ordinary item

- - - - -

Prior year adjustments

- - - - -

Equity capital

35.80 36.50 36.50 36.50 36.40

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

- - - - -

Agg.of non promotoholding (%)

- - - - -

OPM (%)

45.87 35.93 12.05 25.26 32.29

GPM (%)

47.02 37.82 15.80 28.92 35.59

NPM (%)

35.57 26.15 7.47 17.64 24.79
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com